Comparing Rifaximin vs Xifaxan
| Rifaximin | Xifaxan (rifaximin) |
|
|---|
| Rifaximin | Xifaxan (rifaximin) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hepatic Encephalopathy, Irritable Bowel Syndrome with Diarrhea, Irritable Bowel Syndrome, Crohn's Disease, Traveler's Diarrhea, Diarrhea, Diarrhea - Chronic. Rifaximin may also be used... View more |
Prescription only
Prescribed for Hepatic Encephalopathy, Irritable Bowel Syndrome with Diarrhea, Irritable Bowel Syndrome, Traveler's Diarrhea, Diarrhea. Xifaxan may also be used for purposes not listed in this... View more |
Related suggestions Irritable Bowel Syndrome
Irritable Bowel Syndrome with Diarrhea
|
|||||||
| More about Rifaximin | More about Xifaxan (rifaximin) | ||||||||
| Ratings & Reviews | |||||||||
|
Rifaximin has an average rating of 6.6 out of 10 from a total of 158 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 32% reported a negative effect. |
Xifaxan has an average rating of 6.6 out of 10 from a total of 96 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 34% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Rifaximin side effects |
View all Xifaxan side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Xifaxan prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Xifaxan |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
10.19 hours |
10.19 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 91 drugs are known to interact with Rifaximin:
|
A total of 91 drugs are known to interact with Xifaxan:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
May 25, 2004 |
May 25, 2004 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Xifaxan
Xifaxan (rifaximin) is used to treat travelers' diarrhea, irritable bowel syndrome with diarrhea ...
Constulose
Constulose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Enulose
Enulose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Duphalac
Duphalac is a laxative used to treat chronic constipation by drawing water into the colon ...
Kristalose
Kristalose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Generlac
Generlac is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Neomycin
Neomycin is used for bowel preparation, diarrhea, hepatic coma, hepatic encephalopathy
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.